The Anti-Coronavirus Therapies (ACT) Trials: Design, Baseline Characteristics, and Challenges

John Eikelboom, Sumathy Rangarajan, Sanjit S. Jolly, Emilie P. Belley-Cote, Richard Whitlock, Heather Beresh, Gayle Lewis, Lizhen Xu, Noel Chan, Shrikant Bangdiwala, Rafael Diaz, Andres Orlandini, Mohamed Hassany, Wadea M. Tarhuni, A. M. Yusufali, Sanjib Kumar Sharma, Anna Kontsevaya, Patricio Lopez-Jaramillo, Alvaro Avezum, Antonio L. DansSean Wasserman, Camilo Felix, Khawar Kazmi, Prem Pais, Denis Xavier, Renato D. Lopes, Otavio Berwanger, Menelas Nkeshimana, William Harper, Mark Loeb, Shurjeel Choudhri, Michael E. Farkouh, Jackie Bosch, Sonia S. Anand, Salim Yusuf

Research output: Articles / NotesScientific Articlepeer-review

6 Scopus citations

Fingerprint

Dive into the research topics of 'The Anti-Coronavirus Therapies (ACT) Trials: Design, Baseline Characteristics, and Challenges'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science